Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine

NCT04962893 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

349

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: SARS-CoV-2 VLP Vaccine-Wuhan
BIOLOGICAL: SARS-CoV-2 VLP Vaccine-Alpha (British) variant
BIOLOGICAL: SARS-CoV-2 VLP Vaccine-Wuhan+Alpha variant

Sponsor

Ihsan GURSEL, PhD, Prof.

Collaborators

[object Object]
[object Object]
[object Object]